Based on the numerous ongoing clinical efforts exploring the possible synergistic effects of immunotherapy combined with conventional cancer treatments, we designed an immunotherapy combination study with XRT and anti-PD-L1 therapy (Fig. 4a). This evidence concerns the gene CD274 and cancer.